iifl-logo-icon 1

Mangalam Drugs and Organics Ltd Cash Flow Statement

105.69
(-0.36%)
Jan 16, 2025|03:31:09 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mangalam Drugs FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

39.51

6.25

29.34

31.18

Depreciation

-9.17

-8.21

-6.56

-5

Tax paid

-11.54

2

-9.45

-8.9

Working capital

27.78

-24.07

15.15

-3.81

Other operating items

Operating

46.57

-24.03

28.47

13.44

Capital expenditure

25.77

14.78

15.88

42.69

Free cash flow

72.34

-9.25

44.35

56.13

Equity raised

175.09

167.79

137.94

96.2

Investing

0

-0.02

-1.4

1.4

Financing

22.13

-8.39

10.39

15.72

Dividends paid

0

0

0

0

Net in cash

269.57

150.13

191.28

169.46

Mangalam Drugs : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.